Published in In Vivo on April 25, 2006
Collection, Storage, and Preparation of Human Blood Cells. Curr Protoc Cytom (2015) 0.75
Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet (2003) 1.60
Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res (2003) 1.44
Cytokines in head and neck cancer. Cytokine Growth Factor Rev (2006) 1.24
Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proc Natl Acad Sci U S A (2001) 1.17
Inhibition of TRPM2 cation channels by N-(p-amylcinnamoyl)anthranilic acid. Br J Pharmacol (2006) 1.16
Developmental waves of mechanosensitivity acquisition in sensory neuron subtypes during embryonic development. EMBO J (2009) 1.15
B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells. Blood (2002) 1.08
Glandular tissue from human pancreas and salivary gland yields similar stem cell populations. Eur J Cell Biol (2009) 1.06
Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas. Cancer Lett (2003) 1.06
Isolation and characterization of adult stem cells from human salivary glands. Stem Cells Dev (2008) 1.05
A case of central sleep apnea strictly dependent upon REM-sleep. J Neurol (2010) 1.02
Role of cytokines in head and neck squamous cell carcinoma. Expert Rev Anticancer Ther (2006) 1.01
Application of the Vibrant Soundbridge to unilateral osseous atresia cases. Laryngoscope (2009) 1.01
Analysis of plasmacytoid and myeloid dendritic cells in nasal epithelium. Clin Vaccine Immunol (2006) 0.97
Innate signaling in otitis media: pathogenesis and recovery. Curr Allergy Asthma Rep (2011) 0.96
The role of DNA sensing and innate immune receptor TLR9 in otitis media. Innate Immun (2011) 0.94
Stem cells in squamous head and neck cancer. Crit Rev Oncol Hematol (2011) 0.94
N-(p-amylcinnamoyl)anthranilic acid (ACA): a phospholipase A(2) inhibitor and TRP channel blocker. Cardiovasc Drug Rev (2007) 0.94
Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer. In Vivo (2008) 0.93
Permanent up-regulation of regulatory T-lymphocytes in patients with head and neck cancer. Int J Mol Med (2010) 0.93
International consensus on Vibrant Soundbridge® implantation in children and adolescents. Int J Pediatr Otorhinolaryngol (2010) 0.92
Application of the Vibrant Soundbridge in bilateral congenital atresia in toddlers. Acta Otolaryngol (2010) 0.91
Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha. Immunology (2009) 0.90
The Lübeck flowchart for functional and aesthetic rehabilitation of aural atresia and microtia. Otol Neurotol (2012) 0.90
Decreased levels of circulating regulatory NK cells in patients with head and neck cancer throughout all tumor stages. Anticancer Res (2009) 0.89
Impaired monocyte function in cancer patients: restoration with a cyclooxygenase-2 inhibitor. FASEB J (2002) 0.89
The Oral Serine Protease Inhibitor WX-671 - First Experience in Patients with Advanced Head and Neck Carcinoma. Breast Care (Basel) (2008) 0.87
Increased cytokine secretion in head and neck cancer upon p38 mitogen-activated protein kinase activation. Int J Mol Med (2007) 0.86
Yeast Gcn4p stabilization is initiated by the dissociation of the nuclear Pho85p/Pcl5p complex. Mol Biol Cell (2006) 0.86
Inflammatory pseudotumor of the hypopharynx: clinical diagnosis, immunohistochemical findings and treatment of this rare disease. In Vivo (2009) 0.86
The psychosocial consequences of reconstruction of severe ear defects or third-degree microtia with rib cartilage. Aesthet Surg J (2008) 0.85
Cytokine changes in response to radio-/chemotherapeutic treatment in head and neck cancer. Anticancer Res (2013) 0.84
Metastases of squamous cell carcinoma of the head and neck show increased levels of nucleotide excision repair protein XPF in vivo that correlate with increased chemoresistance ex vivo. Int J Oncol (2010) 0.84
Sleep apnoea in patients after treatment of head neck cancer. Acta Otolaryngol (2009) 0.84
Induction of c-Myc-dependent cell proliferation through toll-like receptor 3 in head and neck cancer. Int J Mol Med (2008) 0.84
Secretion of tumor-promoting and immune suppressive cytokines by cell lines of head and neck squamous cell carcinoma. In Vivo (2006) 0.83
Established and novel NF-κB inhibitors lead to downregulation of TLR3 and the proliferation and cytokine secretion in HNSCC. Oral Oncol (2011) 0.83
Activated B cells mediate efficient expansion of rare antigen-specific T cells. Hum Immunol (2007) 0.83
Functional characterization of novel mutations affecting survivin (BIRC5)-mediated therapy resistance in head and neck cancer patients. Hum Mutat (2012) 0.83
LPS-induced mucin expression in human sinus mucosa can be attenuated by hCLCA inhibitors. J Endotoxin Res (2007) 0.82
Head and neck cancer triggers increased IL-6 production of CD34+ stem cells from human cord blood. In Vivo (2007) 0.82
mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinoma. Oncol Rep (2011) 0.82
Cartilage tissue engineering using resorbable scaffolds. J Tissue Eng Regen Med (2008) 0.81
Phosphorylation of STAT3 in head and neck cancer requires p38 MAPKinase, whereas phosphorylation of STAT1 occurs via a different signaling pathway. Anticancer Res (2011) 0.81
Functional alteration of myeloid dendritic cells through head and neck cancer. Anticancer Res (2007) 0.80
Toll-like receptor modulation in head and neck cancer. Crit Rev Immunol (2008) 0.80
Grading system for the selection of patients with congenital aural atresia for active middle ear implants. Neuroradiology (2013) 0.79
Effect of dexamethasone and ACC on bacteria-induced mucin expression in human airway mucosa. Am J Respir Cell Mol Biol (2007) 0.79
Dexamethasone and N-acetyl-cysteine attenuate Pseudomonas aeruginosa-induced mucus expression in human airways. Pulm Pharmacol Ther (2010) 0.79
Increased phosphorylation of STAT5b, but not STAT5a, in nasal polyps. Am J Rhinol Allergy (2015) 0.79
Generation of an autologous cell system for immunotherapy of squamous cell carcinoma of the head and neck. Anticancer Res (2005) 0.79
A novel xenogeneic co-culture system to examine neuronal differentiation capability of various adult human stem cells. PLoS One (2011) 0.79
Biodistribution and radioimmunotherapy of SCCHN in xenotransplantated SCID mice with a 131I-labelled anti-EpCAM monoclonal antibody. Anticancer Res (2007) 0.79
Psychometric validation of the youth quality of life-facial differences questionnaire in patients following ear reconstruction with rib cartilage in microtia. Plast Reconstr Surg (2012) 0.79
A prospective evaluation of psychosocial outcomes following ear reconstruction with rib cartilage in microtia. J Plast Reconstr Aesthet Surg (2009) 0.78
Effect of steroids, acetyl-cysteine and calcium-activated chloride channel inhibitors on allergic mucin expression in sinus mucosa. Laryngoscope (2008) 0.78
Plasmacytoid dendritic cell subpopulations in head and neck squamous cell carcinoma. Oncol Rep (2011) 0.78
Head and neck cancer triggers the internalization of TLR3 in natural killer cells. Int J Mol Med (2007) 0.78
Polyadenylation of rRNA- and tRNA-based yeast transcripts cleaved by internal ribozyme activity. Curr Genet (2003) 0.78
Human mesenchymal stromal cells from adipose tissue of the neck. Eur Arch Otorhinolaryngol (2012) 0.78
Soluble CD44v6 is not a sensitive tumor marker in patients with head and neck squamous cell cancer. Anticancer Res (2005) 0.77
Effect of head and neck cancer supernatant and CpG-oligonucleotides on migration and IFN-alpha production of plasmacytoid dendritic cells. Anticancer Res (2009) 0.77
Phase I/II clinical study on safety and antivascular effects of paclitaxel encapsulated in cationic liposomes for targeted therapy in advanced head and neck cancer. Head Neck (2013) 0.77
Biodistribution of 131I-labeled anti-CK8 monoclonal antibody in HNSCC in xenotransplanted SCID mice. Anticancer Res (2011) 0.77
In vivo studies on the availability and toxicity of antisense oligonucleotides in bladder cancer. In Vivo (2009) 0.77
Decreased migration of myeloid dendritic cells through increased levels of C-reactive protein. Anticancer Res (2008) 0.77
The MEK1/2-ERK1/2 pathway is activated in chronic rhinosinusitis with nasal polyps. Arch Immunol Ther Exp (Warsz) (2014) 0.76
The number of CD161 positive Th17 cells are decreased in head and neck cancer patients. Cell Immunol (2011) 0.76
Amplification options in unilateral aural atresia: an active middle ear implant or a bone conduction device? Otol Neurotol (2014) 0.76
Toll-like receptor interference in myeloid dendritic cells through head and neck cancer. Anticancer Res (2007) 0.76
Up-regulation of NK cell function against head and neck cancer in response to ss-isRNA requires TLR7. Int J Oncol (2008) 0.76
Limited suitability of EpCAM for molecular staging of tumor borders in head and neck cancer. Anticancer Res (2006) 0.76
Cytokine release of human NK cells solely triggered with Poly I:C. Cell Immunol (2010) 0.76